4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine Induces Immunogenic Cell Death in Colon and Pancreatic Carcinoma Models as a Single Agent

RNA sequencing experiments were conducted on PANC-1 human pancreatic cancer cells treated with Docosahexaenoyl difluorodeoxycytidine (DHA–dFdC), dFdC, or vehicle control in vitro.